Pam Randhawa, CEO and Founder of Empiriko, has 25 years of leadership experience in the healthcare/life science industries with expertise ranging from policy, corporate strategy, product development, and advanced analytics for Fortune 500 companies, startups, and government. Prior to founding Empiriko, she co-founded AgroGreen Biofuels, an alternative biofuels technology company. Previously, Pam held several executive positions with major healthcare technology companies.

Pam currently serves on the Board of Directors (past Chair) of the Massachusetts Biotechnology Council and on the Board of Directors of the Massachusetts Life Sciences Center (MLSC), a state investment agency responsible for $1.6 billion fund to support life sciences innovation. She also serves on the Board of Directors of Hercules Capital with $4.2 billion assets under management.

Pam has previously served in leadership roles on several boards/councils focused on strategic initiatives promoting scientific innovation as a vehicle for the public good. These include the World Economic Forum’s Global Future Council on Biotechnology; as Chair of the NSF/NIJ Industrial Advisory Board of Center for Advanced Research in Forensic Science; and the NIH review panel for SBIR/STTR Commercialization Readiness Pilot Program.

Pam has a strong interest in reinvesting in the community and mentoring the next generation of thought leaders as a previous member of the Commonwealth of Massachusetts Economic Development Planning Council, the Women’s Workforce Council, and as a judge for the Harvard Business School’s New Venture Competition.

Pam holds a B.A. in economics from the University of Rajasthan, India, and an MPM from the Heinz School of Public Policy & Management at Carnegie-Mellon University. She developed her passion for analytics as a member of the MIT blackjack card counting team featured in the movie “21”.